- Home
- NWL vs BLTE Comparison
NWL vs BLTE Comparison
Compare NWL & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWL
- BLTE
- Stock Information
- Founded
- NWL 1903
- BLTE 2018
- Country
- NWL United States
- BLTE United States
- Employees
- NWL N/A
- BLTE N/A
- Industry
- NWL Plastic Products
- BLTE Biotechnology: Pharmaceutical Preparations
- Sector
- NWL Industrials
- BLTE Health Care
- Exchange
- NWL Nasdaq
- BLTE Nasdaq
- Market Cap
- NWL 2.4B
- BLTE 2.1B
- IPO Year
- NWL N/A
- BLTE 2022
- Fundamental
- Price
- NWL $5.81
- BLTE $63.22
- Analyst Decision
- NWL Buy
- BLTE Strong Buy
- Analyst Count
- NWL 9
- BLTE 4
- Target Price
- NWL $7.53
- BLTE $96.67
- AVG Volume (30 Days)
- NWL 9.1M
- BLTE 60.2K
- Earning Date
- NWL 08-01-2025
- BLTE 08-08-2025
- Dividend Yield
- NWL 4.81%
- BLTE N/A
- EPS Growth
- NWL N/A
- BLTE N/A
- EPS
- NWL N/A
- BLTE N/A
- Revenue
- NWL $7,495,000,000.00
- BLTE N/A
- Revenue This Year
- NWL N/A
- BLTE N/A
- Revenue Next Year
- NWL $1.53
- BLTE N/A
- P/E Ratio
- NWL N/A
- BLTE N/A
- Revenue Growth
- NWL N/A
- BLTE N/A
- 52 Week Low
- NWL $4.22
- BLTE $43.70
- 52 Week High
- NWL $11.78
- BLTE $86.53
- Technical
- Relative Strength Index (RSI)
- NWL 56.40
- BLTE 56.22
- Support Level
- NWL $5.59
- BLTE $56.10
- Resistance Level
- NWL $6.12
- BLTE $64.20
- Average True Range (ATR)
- NWL 0.23
- BLTE 2.56
- MACD
- NWL 0.05
- BLTE 0.56
- Stochastic Oscillator
- NWL 71.56
- BLTE 87.90
About NWL Newell Brands Inc.
Newell Brands Inc is an American consumer goods company with a strong portfolio of well-known brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.